چاپ صفحه |  صفحه نخست سامانه |  چکیده مقاله |  نویسندگان |  دانلود مقاله | دانشگاه علوم پزشکی تبریز |
| The 2012 Access to Medicine Index mostly focuses on access to medicines for communicable diseases in developing countries. Nevertheless, as emphasised in an Editorial in The Lancet Oncology, the burden of non-communicable diseases such as cancer has greatly increased in these countries, and is expected to impose an extra burden on their health-care systems.1 The eastern Mediterranean is predicted to face the most exponential increase in cancer incidence in the next decade, underlining the need for further health support and education in these countries.2 Excluded from the latest Access to Medicine Index, Iran has the highest incidence of cancer in the Middle East at 100 cases per 100 000 population per year, leading to 105 deaths every day.3 Such substantial rises in the number of patients with cancer would warrant timely and abundant access to anticancer drugs—a constant challenge to health-care providers, including pharmaceutical companies, in Iran. These companies have to overcome not only the obstacles of low-resource conditions in developing countries, but also the increasing multilateral international sanctions against Iran. Although these sanctions are not on humanitarian supplies, such as food and medicine, they have indirect consequences leading to shortages of both patented and generic cancer drugs, possibly because international pharmaceutical companies are reluctant to transact with Iran. Whereas delays in delivery of medical supplies to patients with cancer can be life-threatening, even those who can access their daily required medicines are not guaranteed aff ordable prices. Emphasis on the pivotal role of the pharmaceutical industry in reducing barriers to medicine access, and inclusion of developing countries under sanction, such as Iran, in the Access to Medicine Index might improve medicine availability for the thousands of patients with cancer in these countries. Furthermore, a legal international conduit for medicines could be started to tackle the issue in Iran. Global events such as the annual World Cancer Day4—of which a main target is increased access to, and treatment of, patients with cancer— should be used to champion the global fi ght against cancer, with the aim to overcome political, cultural, and national diff erences |
| نویسنده | نفر چندم مقاله |
|---|---|
| صمد اسلام جمال گلزاری | اول |
| کامیار قابیلی | دوم |
| رضا ریخته گر غیاثی | پنجم |
| نام فایل | تاریخ درج فایل | اندازه فایل | دانلود |
|---|---|---|---|
| PIIS1470204513700366.pdf | 1398/10/12 | 36255 | دانلود |
